{"created":"2025-06-17T04:05:36.869558+00:00","id":2040743,"links":{},"metadata":{"_buckets":{"deposit":"7a647ba7-5276-4c5f-bb37-d9ff64521c0f"},"_deposit":{"created_by":7,"id":"2040743","owner":"7","owners":[7],"pid":{"revision_id":0,"type":"depid","value":"2040743"},"status":"published"},"_oai":{"id":"oai:hiroshima.repo.nii.ac.jp:02040743","sets":["1730444907710"]},"author_link":[],"item_1617186331708":{"attribute_name":"Title","attribute_value_mlt":[{"subitem_title":"Effect of haemodiafiltration versus haemodialysis on vascular access patency when starting haemodialysis","subitem_title_language":"en"}]},"item_1617186419668":{"attribute_name":"Creator","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Yoshida, Mahoko","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Maeoka, Yujiro","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Takahashi, Akira","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Ishiuchi, Naoki","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Osaki, Yosuke","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Sasaki, Kensuke","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Masaki, Takao","creatorNameLang":"en"}]}]},"item_1617186476635":{"attribute_name":"Access Rights","attribute_value_mlt":[{"subitem_access_right":"embargoed access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_f1cf"}]},"item_1617186499011":{"attribute_name":"Rights","attribute_value_mlt":[{"subitem_rights":"This is a pre-copyedited, author-produced version of an article accepted for publication in Nephrology Dialysis Transplantation following peer review. The version of record Mahoko Yoshida, Yujiro Maeoka, Akira Takahashi, Naoki Ishiuchi, Yosuke Osaki, Kensuke Sasaki, Takao Masaki,Effect of haemodiafiltration versus haemodialysis on vascular access patency when starting haemodialysis, Nephrology Dialysis Transplantation, 2025, gfaf017, is available online at:https://doi.org/10.1093/ndt/gfaf017.","subitem_rights_language":"en"},{"subitem_rights":"This is not the published version. Please cite only the published version.","subitem_rights_language":"en"},{"subitem_rights":"この論文は出版社版ではありません。引用の際には出版社版をご確認、ご利用ください。","subitem_rights_language":"ja"}]},"item_1617186609386":{"attribute_name":"Subject","attribute_value_mlt":[{"subitem_subject":"haemodiafiltration","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"haemodialysis","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"patency rate","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"vascular access","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"vascular access interventional therapy","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_1617186626617":{"attribute_name":"Description","attribute_value_mlt":[{"subitem_description":"Background\nHaemodiafiltration (HDF) therapy improves the prognosis by reducing inflammation and oxidative stress and improving endothelial function. These factors contribute to vascular access (VA) stenosis, one of the most common complications in patients on haemodialysis (HD) or HDF. This study aimed to assess the efficacy of HDF on VA patency.\nMethods\nThis multicentre, prospective, observational study with post hoc analysis included 612 patients among 643 who underwent VA procedures and started dialysis between April 2012 and March 2021. A total of 516 patients were on HD since starting dialysis, while 96 switched to HDF after starting dialysis. One-to-one propensity score matching was performed to compare the 24-month patency rates of VA between groups by Kaplan–Meier and logrank tests, and a Cox proportional hazards regression analysis was used to identify factors affecting patency rates.\nResults\nThere were 87 patients in each group. The 24-month primary patency rates were 74.2% for HDF and 47.7% for HD (P < .001). A multivariate Cox proportional hazards analysis showed that a history of cardiovascular disease {hazard ratio [HR] 2.29 [95% confidence interval (CI) 1.21–4.34], P = .01} and higher haemoglobin A1c values [HR 1.37 (95% CI 1.00–1.82), P = .04] were associated with poor 24-month primary patency. However, HDF [HR 0.30 (95% CI 0.16–0.56), P < .001] and use of statins [HR 0.50 (95% CI 0.27–0.94), P = .03] were associated with better patency. A stratified analysis showed that HRs for loss of VA patency were lower in patients with HDF than in those with HD in the subgroups of ≥65 years, male sex, radiocephalic arteriovenous fistula, a history of diabetes mellitus or cardiovascular disease, haemoglobin concentrations <10 g/dl and albumin concentrations <3.5 g/dl.\nConclusions\nHDF potentially improves VA patency rates compared with HD, even in patients with cardiovascular disease or diabetes, commonly associated with poor patency.","subitem_description_language":"en","subitem_description_type":"Abstract"}]},"item_1617186643794":{"attribute_name":"Publisher","attribute_value_mlt":[{"subitem_publisher":"Oxford University Press","subitem_publisher_language":"en"}]},"item_1617186660861":{"attribute_name":"Date","attribute_value_mlt":[{"subitem_date_issued_datetime":"2026-01-24","subitem_date_issued_type":"Available"}]},"item_1617186702042":{"attribute_name":"Language","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_1617187056579":{"attribute_name":"Bibliographic Information","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2025-01-24","bibliographicIssueDateType":"Issued"},"bibliographicPageStart":"gfaf017","bibliographic_titles":[{"bibliographic_title":"Nephrology Dialysis Transplantation","bibliographic_titleLang":"en"}]}]},"item_1617258105262":{"attribute_name":"Resource Type","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_1617265215918":{"attribute_name":"Version Type","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_ab4af688f83e57aa","subitem_version_type":"AM"}]},"item_1617353299429":{"attribute_name":"Relation","attribute_value_mlt":[{"subitem_relation_type":"isVersionOf","subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.1093/ndt/gfaf017","subitem_relation_type_select":"DOI"}}]},"item_1617605131499":{"attribute_name":"File","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2026-01-24"}],"fileDate":[{"fileDateType":"Available","fileDateValue":"2026-01-24"}],"filename":"NDT_gfaf017.pdf","filesize":[{"value":"1.7 MB"}],"format":"application/pdf","url":{"objectType":"fulltext","url":"https://hiroshima.repo.nii.ac.jp/record/2040743/files/NDT_gfaf017.pdf"},"version_id":"389d2a9c-fbac-4acb-b281-bf333dbc9ce1"}]},"item_1732772494514":{"attribute_name":"備考","attribute_value_mlt":[{"subitem_text_language":"en","subitem_text_value":"The full-text file will be made open to the public on 24 January 2026 in accordance with publisher's 'Terms and Conditions for Self-Archiving'"}]},"item_title":"Effect of haemodiafiltration versus haemodialysis on vascular access patency when starting haemodialysis","item_type_id":"40036","owner":"7","path":["1730444907710"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2025-06-17"},"publish_date":"2025-06-17","publish_status":"0","recid":"2040743","relation_version_is_last":true,"title":["Effect of haemodiafiltration versus haemodialysis on vascular access patency when starting haemodialysis"],"weko_creator_id":"7","weko_shared_id":-1},"updated":"2025-06-17T04:21:57.710472+00:00"}